-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
Biallelic HMBS Inactivation Defines a Homogenous Clinico-Molecular Subtype of Hepatocellular Carcinoma
Study
EGAS00001005986
-
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Study
EGAS00001002696
-
Whole genome sequencing and whole exome sequencing of DIPG tumors and matched normal tissue
Study
EGAS00001000575
-
CRISPR_Screening_of_Brazilian_Acral_Melanoma_Cell_Lines
Study
EGAS00001008230
-
Whole exome sequencing of papillary thyroid carcinoma in the Chinese population
Study
EGAS00001001268
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Whole exome sequencing data for paired non-serous endometrial and ovarian carcinomas from 27 patients with concurrent tumours.
Study
EGAS00001008259
-
Angiosarcoma_whole_exome
Study
EGAS00001000588
-
Genomic characterization of NUT midline carcinoma
Study
EGAS00001001934
-
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Study
EGAS00001005201
-
Transcriptional and translational alterations induced by BET protein inhibition and its combination with Omaveloxolone in acute myeloid leukemia
Study
EGAS00001008404
-
Sclerosing epithelioid fibrosarcoma case report
Study
EGAS00001005214
-
Hyperhaploid Multiple Myeloma
Study
EGAS00001003203
-
Detecting and tracking circulating tumour DNA copy number profiles during first line chemotherapy in oesophagogastric adenocarcinoma
Study
EGAS00001003695
-
Sensitive detection of MYCN amplified neuroblastoma in blood samples with structural variants using whole genome sequencing
Study
EGAS00001008441
-
The ITCC-P4 PDX platform of pediatric cancers for preclinical testing
Study
EGAS00001008330
-
Preclinical trial supports dual inhibition of BCL2 and aurora kinase for MYCN-amplified high-risk neuroblastoma
Study
EGAS00001008494
-
Spatial Omics Resolves Adrenergic and Mesenchymal Cell States in Neuroblastoma
Study
EGAS00001008537
-
Whole genome and RNAseq analysis of pediatric osteosarcoma
Study
EGAS00001003201
-
CD74-NRG1 fusions in lung adenocarcinoma
Study
EGAS00001000653
-
Independent development of lymphoid and histiocytic malignancies from a shared early precursor
Study
EGAS00001001353
-
Reconstruction of complex rearrangement patterns causing the initiation of clear cell renal cell carcinoma.
Study
EGAS00001004015
-
Germline variants in patients diagnosed with both uveal and cutaneous melanoma
Study
EGAS00001007584
-
Exome Sequencing to Define the Landscape of Plasma Cells in Systemic Light chain Amyloidosis
Study
EGAS00001001418
-
Diverse modes of genomic alterations in hepatocellular carcinoma
Study
EGAS00001000824
-
Skin Adenocarcinoma Genome Sequencing
Study
EGAS00001001052
-
Exploring germline and somatic mutagenesis in the extended family with germline pathogenic variant in POLD1
Study
EGAS00001006434
-
Genomic landscape and PD-1 blockade in Natural-killer/T cell lymphoma
Study
EGAS00001003828
-
Renal Cell Carcinoma Tumors From S-TRAC trial (NCT00375674) Exome Sequencing
Study
EGAS00001006529
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
Evolutionary dynamics of residual disease in human glioblastoma
Study
EGAS00001003043
-
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
Study
EGAS00001006576
-
RNA sequencing CYLD cutaneous syndrome
Study
EGAS00001003841
-
Revealing active mutational processes in tumours using DigiPico/MutLX at unprecedented accuracy
Study
EGAS00001003555
-
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Study
EGAS00001007873
-
RNAseq on 20 samples of multiple myeloma patients and 3 normal plasma cells.
Study
EGAS00001004347
-
Whole-genome sequencing in 14 cases and whole-exome sequencing in 90 cases of Chinese ESCC
Study
EGAS00001001487
-
scRNA-seq of patient-derived PDAC organoids and matched CAFs
Study
EGAS00001006661
-
Characterization of MCSP+ melanoma DCC and MelDCC lines
Study
EGAS00001006702
-
Genomic analysis reveals novel secondary drivers and progression pathways in skin basal cell carcinoma
Study
EGAS00001001540
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Single-cell profiling maps the spectrum of crosstalk between glioma cells and tumor associated macrophages
Study
EGAS00001002185
-
WES used for direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Study
EGAS00001002050
-
Somatic_Variation_Angiosarcoma
Study
EGAS00001002610
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Whole exome sequencing of longitudinal samples from a melanoma patient receiving MEK plus CDK4/6 inhibitor therapy.
Study
EGAS00001002846
-
Pediatric HGG WES and RNA-Seq
Study
EGAS00001005687
-
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
Study
EGAS00001001281
-
Profiling of childhood neuroblastoma and the immune microenvironment by single-cell sequencing of RNA and TCR
Study
EGAS00001006823